Obstructive sleep apnea (OSA) is a growing and common disorder found in a large global population. Unfortunately, many tend to neglect this disorder without anticipating its chronic and serious health consequences. In this work we demonstrate a prototype portable, low-cost and facile sensing platform that can identify microRNA based molecular markers of OSA including monitoring its severity. An affordable commercial grade gold coated copper cladded laminate sheet was used for fabricating the electrochemical biosensor. The electrode surface was nanotextured to extend a dense and high surface area to significantly improve the sensitivity. A limit of detection of 0.7 nM could be obtained for mir-21 target with a very promising stability of more than 600 days at − 20 °C storage. Clinical utility of the fabricated sensor was established with a rsd of 7.3 % using RNA extracted from PBMC isolated blood samples of various (n = 12) OSA patients and healthy individuals (n = 7). The electrochemical sensing results were compared and satisfactorily validated with ΔCt values obtained from RT-PCR and AHI values from Polysomnography test. Clinical validation not only indicated potentials for an easy portable sensing technology but also a method to monitor patient’s severity of the disorder. These test results have been further supported by statistical analysis that enabled prediction of correlation of OSA with other common lifestyle disorders such as Obesity, liver disorder and diabetes. Overall, the proposed platform holds a strong potential as a reliable alternative to the existing OSA detection technology like Polysomnography that is complex and requires long data acquisition time.